According to a paper presented at the American Chemical Society conference this week, Dipanjan Pan and his team from the University of Illinois said they may have found a way to stop cancer cell growth.
The work is in very early stages, but has shown success in stopping breast cancer and melanoma cell growth in lab tests.
Pan's technique uses nanotechnology to deliver a synthesised element similar to the venom found in bees, snakes and scorpions.
The general problem with injecting someone with venom is that there can be harmful side effects.
The properties in venom that destroy cancer cells can have the same effect on healthy cells -- much in the same way chemotherapy causes cell damage, and painful side effects, while treating cancer.
"Since it's synthetic, there's no ambiguity" in what the substance contains, Pan was quoted as saying by CNN.
The synthetic material is then delivered to cancer cells using nanotechnology. In "camouflaging the whole toxin as a part of the nanoparticle," Pan said, it bypasses healthy cells and is attracted to only the cancer cells.
Attached to the cancer cells, these nanoparticles with the synthesised venom can either slow down or stop cancer cell growth, and may ultimately stop the cancer from spreading.
"That's what we are interested in -- those are the cells responsible for metastasizing and also responsible for having the cancer cells grow back," Pan said.
"If we can target better using this technique, we potentially have a better cancer treatment," he said.
Unlike chemotherapy, this more targeted technique would, in theory, only affect cancer cells. If it is successful, this natural agent found in venom could become the basis for a whole legion of cancer-fighting drugs.
Pan's lab will now try the synthesised venom and nanotechnology combination on cancer cells in rats and pigs. If successful, they will then try the technique on humans. He predicts that step could happen in the next three to five years.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
